Clinical impact of 68Ga-PSMA-11 PET on patient management and outcome, including all patients referred for an increase in PSA level during the first year after its clinical introduction.
Müller J, Ferraro DA, Muehlematter UJ, Garcia Schüler HI, Kedzia S, Eberli D, Guckenberger M, Kroeze SGC, Sulser T, Schmid DM, Omlin A, Müller A, Zilli T, John H, Kranzbuehler H, Kaufmann PA, von Schulthess GK, Burger IA.
Müller J, et al.
Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):889-900. doi: 10.1007/s00259-018-4203-0. Epub 2018 Nov 28.
Eur J Nucl Med Mol Imaging. 2019.
PMID: 30488099